Fortis Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.42M Buy
3,684
+477
+15% +$487K 0.5% 35
2026
Q1
$2.95M Buy
3,207
+203
+7% +$206K 0.39% 42
2025
Q4
$3.23M Buy
3,004
+1,391
+86% +$1.33M 0.48% 32
2025
Q3
$1.23M Sell
1,613
-158
-9% -$118K 0.2% 81
2025
Q2
$1.38M Buy
1,771
+37
+2% +$28.8K 0.25% 61
2025
Q1
$1.43M Sell
1,734
-213
-11% -$177K 0.29% 55
2024
Q4
$1.87M Buy
1,947
+117
+6% +$96.9K 0.64% 26
2024
Q3
$1.62M Sell
1,830
-806
-31% -$725K 0.54% 31
2024
Q2
$2.39M Buy
2,636
+531
+25% +$425K 0.86% 17
2024
Q1
$1.64M Sell
2,105
-8
-0.4% -$5.69K 0.69% 23
2023
Q4
$1.23M Buy
2,113
+772
+58% +$451K 0.66% 26
2023
Q3
$720K Sell
1,341
-66
-5% -$34K 0.46% 38
2023
Q2
$660K Buy
1,407
+539
+62% +$226K 0.39% 45
2023
Q1
$298K Sell
868
-269
-24% -$90.7K 0.16% 84
2022
Q4
$416K Buy
+1,137
New +$403K 0.25% 61

Other funds holding LLY

Fortis Capital Advisors's LLY Position: Q2 2026 in Review

Fortis Capital Advisors increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $487K and bringing the position to 3,684 shares worth $4.42M. The position accounts for 0.5% of the portfolio, ranked #35.

Fortis Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortis Capital Advisors held 3,684 shares of Eli Lilly worth $4.42M as of Q2 2026.
  • Fortis Capital Advisors bought 477 Eli Lilly shares in Q2 2026, an estimated $487K.
  • Eli Lilly made up 0.5% of Fortis Capital Advisors's portfolio in Q2 2026, its #35 holding.
  • Fortis Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.